Catherine Berry

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Endothelial Cells

Protein Protein

Immune Response

Respiratory Syndrome Coronavirus

Top Venues

Nature communications

Science translational medicine

Communications medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G Anosova, Lu Li, Tim Tibbitts, Dean Huang, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates. Nature communications 14 (1) (2023)
Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G Anosova, Lu Li, Tim Tibbitts, Dean Huang, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates. Nature communications 14 (1) (2023)
Catherine Berry, Vincent Pavot, Natalie G Anosova, Michael Kishko, Lu Li, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Sheila Cummings, Dinesh S Bangari, Swagata Kar, Caroline Atyeo, Yixiang Deng, Galit Alter, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier
Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters. Communications medicine 3 (1) (2023)
Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G Anosova, Lu Li, Tim Tibbitts, Dean Huang, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier
Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates. Nature communications 14 (1) (2023)
Vincent Pavot, Catherine Berry, Michael Kishko, Natalie G Anosova, Dean Huang, Tim Tibbitts, Alice Raillard, Sylviane Gautheron, Cindy Gutzeit, Marguerite Koutsoukos, Roman M Chicz, Valerie Lecouturier
Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates. Nature communications 13 (1) (2022)
Joseph R Francica, Barbara J Flynn, Kathryn E Foulds, Amy T Noe, Anne P Werner, Ian N Moore, Matthew Gagne, Timothy S Johnston, Courtney Tucker, Rachel L Davis, Britta Flach, Sarah O'Connell, Shayne F Andrew, Evan Lamb, Dillon R Flebbe, Saule T Nurmukhambetova, Mitzi M Donaldson, John-Paul M Todd, Alex Lee Zhu, Caroline G Atyeo, Stephanie Fischinger, Matthew J Gorman, Sally A Shin, Venkata-Viswanadh Edara, Katharine A Floyd, Lilin Lai, Seyhan Boyoglu-Barnum, Renee Van De Wetering, Alida Tylor, Elizabeth McCarthy, Valerie Lecouturier, Sophie Ruiz, Catherine Berry, Timothy Tibbitts, Hanne A Elyard, Anthony Cook, Alan Dodson, Laurent Pessiant, Alex Van Ry, Marguerite Koutsoukos, Cindy Gutzeit, I-Ting Teng, Tongqing Zhou, Dapeng Li, Barton F Haynes, Peter D Kwong, Adrian B McDermott, Mark G Lewis, Tong Ming Fu, Roman Chicz, Robbert G van der Most, Kizzmekia S Corbett-Helaire, Mehul S Suthar, Galit Alter, Mario Roederer, Nancy J Sullivan, Daniel C Douek, Barney S Graham, Danilo Casimiro, Robert A Seder
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Science translational medicine 13 (607) (2021)